Conversely, patients with urothelial cell carcinoma who carried the MMP-11 rs131451 polymorphic “CC” genotype were associated with a lower risk of later tumor T status (T1-T4) when compared with those who carried the CT + TT genotype [24]. The gene discussed is MMP11; the disease is transitional cell carcinoma.